Table 1 Correlation between the SOCS7 expression and clinicopathological characteristics in 68 patients with HGSOC
From: SOCS7/HuR/FOXM1 signaling axis inhibited high-grade serous ovarian carcinoma progression
Characteristics | No. Patients (n = 68) | SOCS7 expression | P value | |
|---|---|---|---|---|
Low No. (%) | High No. (%) | |||
Age (years) | Â | Â | Â | 0.357 |
  > 57 | 36 | 22 (61.1%) | 14 (38.9%) |  |
  ≤ 57 | 32 | 16 (50.0%) | 16 (50.0%) |  |
FIGO stage | Â | Â | Â | 0.006 |
  III | 53 | 25 (47.2%) | 28 (52.8%) |  |
  IV | 15 | 13 (86.7%) | 2 (13.3%) |  |
Grade | Â | Â | Â | 0.003 |
  2 | 12 | 2 (16.7%) | 10 (83.3%) |  |
  3 | 56 | 36 (64.3%) | 20 (35.7%) |  |